Insulin and insulin-like growth factors also activate these oncogenic pathways in other target tissues such as the breast, liver, and colorectum; thereby driving the progression of cancers by supporting cellular proliferation and growth, aberrant cancer metabolism, inhibition of cell death, invasion, and metastasis in these tissues [8,80,81]. Here, INS is linked to cancer.